Weight context: discuss appetite, nutrition, and prior medication response
they can repurpose some of Starbucks' old buildings and call it Starcocks
Retatrutide works like other weight loss and type 2 diabetes medications, but what makes it different is that it can target three receptors (triple agonist) at once: GIP (gastric inhibitory polypeptide) receptor GLP-1 (glucagon-like peptide-1) receptor GCG (glucagon) receptor This unique triple-action may make it more effective than GLP-1 and GLP-1/GIP medications
BPC-157, promoted for gut healing and injury recovery, TB-500, marketed for muscle repair and performance, and MOTS-C, associated with metabolism and longevity, have attracted enormous consumer demand without any of the large-scale clinical trials required for standard FDA drug approval
It is specifically approved to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events, such as heart attack or stroke, in patients with established heart disease